Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00375076
Status:
COMPLETED
Last Update Posted:
2009-09-18
First Post:
2006-09-11
Brief Title:
Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Study Overview
Official Title:
Prevention of Venous Thrombosis in Cancer Patients A Prospective Randomized Double-blind Study Comparing Two Different Dosages of Low-molecular Weight Heparin
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In a prospective randomized double-blind trial the effects of two different dosages of LMWH 5000 anti-Xa U od sc and 10 000 anti-Xa U od sc daily on markers of hemostatic system and thrombin generation will be investigated in non-surgical cancer patients will be investigated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None